UBS maintains Buy rating on LRCX, believing an AI-driven WFE supercycle is beginning
AI summary card
UBS maintains Buy rating on LRCX, believing an AI-driven WFE supercycle is beginning
The report argues that LRCX is transitioning from a China-driven SPE cycle to an AI-driven WFE supercycle, with share gains in NAND, DRAM, and foundry creating a path toward nearly $15 in C2028 EPS.
- FQ3:26 revenue reached a record high of $5.84 billion, with non-GAAP EPS of $1.47, above UBS's pre-call estimate of $1.39.
- The company guided to FQ4:26 midpoint revenue of $6.60 billion and midpoint non-GAAP EPS of $1.65, both above UBS's pre-call estimates.
- Management raised its C2026 WFE outlook to approximately $140 billion and indicated that demand is stronger than near-term executable supply.
- UBS believes WFE could approach $190 billion to $200 billion in 2027 and support a range of approximately $240 billion to $250 billion over the longer term.
- UBS maintains its $310 target price, based on about 27x NTM P/E applied to C2027E non-GAAP EPS of $11.58.
Report interpretation
Overview
This is a UBS earnings review and investment view update on LAM RESEARCH CORP. The report's core view is that, after years of SPE growth driven by Chinese demand, LRCX is now entering an AI-driven WFE supercycle. In the short term, FQ3:26 results and FQ4:26 guidance both reflect resilience in revenue, gross margin, and EPS; in the medium term, easing cleanroom supply constraints, greenfield project starts, NAND layer migration, the new Akara tool for DRAM conductor etch, foundry backside power delivery adoption, and selective price increases together form a path for earnings upgrades.
Core views
UBS maintains its Buy rating and $310 target price. The report believes LRCX will be one of the primary beneficiaries of WFE share gains, with WFE share expected to rise from about 11.8% in C2025 to about 13.2% in C2026 and exceed 15% in C2027. UBS raises its C2027/C2028 EPS targets from about $10/$12 to about $12/$15, while in its formal model, 06/28E EPS is $13.88 and 06/29E EPS is $15.00.
Analysis framework
The report combines the company's quarterly results, management guidance, UBS estimates, FactSet, LSEG Eikon, and an industry WFE framework for analysis. Core methods include: breaking down revenue, gross margin, EPS, and service business performance; assessing total WFE demand, cleanroom supply constraints, and greenfield expansion; analyzing share shifts across NAND, DRAM, and foundry/logic segments; and valuing the target price using NTM P/E.
Methodology notes
Price-to-earnings valuation method
UBS uses a P/E valuation approach, deriving the $310 target price from approximately 27x NTM P/E multiplied by C2027E non-GAAP EPS of $11.58.
Wafer fab equipment spending supercycle
Using WFE demand, cleanroom supply, AI capital expenditure, process complexity, and capital intensity per wafer as core variables, the report concludes that LRCX is entering an AI-driven equipment upcycle.
Earnings forecast upgrade
UBS raises its FQ4:26 revenue/EPS estimates from $6.40 billion/$1.57 to $6.70 billion/$1.73, and its CY26E revenue/EPS estimates from $27.0 billion/$6.83 to $27.8 billion/$7.23.
Share changes broken down by NAND, DRAM, and foundry/logic
The report focuses on LRCX's share opportunities in NAND layer migration, DRAM conductor etch, and foundry backside power delivery-related equipment.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- LRCX.USCore covered name
- Strengths
- Benefits from the AI-driven WFE supercycle, NAND layer migration, DRAM conductor etch share gains, foundry backside power delivery demand, and selective price increases; FQ3 revenue hit a record high, and FQ4 guidance was stronger than expected.
- Weaknesses
- Has relatively high exposure to memory, especially NAND, and the service business may become more volatile once industry utilization approaches high levels.
- Comparison
- UBS believes LRCX and AMAT are the primary beneficiaries of WFE share gains, with LRCX WFE share expected to rise from about 11.8% in C2025 to above 15% in C2027.
- Risks
- Macro, trade, regulation, competition, memory demand shocks, and geopolitical risk in China-related business.
- AMATPositive read-across
- Strengths
- LRCX's positive comments on WFE demand and industry expansion are also positive for AMAT.
- Weaknesses
- The report does not provide an independent valuation or rating change for AMAT.
- Comparison
- Like LRCX, a potential beneficiary of WFE share gains.
- Risks
- Industry WFE cycle, equipment supply, and changes in end semiconductor demand.
- KLACPositive read-across
- Strengths
- LRCX's WFE outlook is positive for sentiment across the semiconductor equipment chain, and the report explicitly mentions positive read-across for KLAC.
- Weaknesses
- The report does not elaborate on KLAC's company-level earnings outlook.
- Comparison
- Also a semiconductor equipment-related name, but this report is primarily focused on LRCX.
- Risks
- WFE growth falling short of expectations and volatility in semiconductor capital spending.
- ENTGPositive read-across
- Strengths
- About 75% of its business is tied to wafer starts, and LRCX said industry fab utilization is at or near high levels, which is a positive signal for ENTG.
- Weaknesses
- If utilization peaks, incremental upside elasticity may weaken.
- Comparison
- More exposed to materials and wafer starts, while LRCX has more direct exposure to equipment spending and share gains.
- Risks
- Declining fab utilization and slowing wafer starts.
- ASML.USIndustry comparable and background reference
- Strengths
- The report uses market share charts of equipment makers such as ASML as background comparison for the WFE industry.
- Weaknesses
- The report notes that ASML still believes China WFE will decline this year, differing from UBS's view that China WFE will grow by at least about 10%.
- Comparison
- ASML reflects lithography spending more directly, while LRCX benefits from complementary technology equipment around lithography spending and rising process complexity.
- Risks
- Changes in China WFE, global advanced process capital spending, and the equipment supply chain.
Key data
- RatingBuy12-month rating maintained at Buy.
- Target priceUS$310.00Target price unchanged.
- Current priceUS$265.55As of April 22, 2026.
- FQ3:26 revenueUS$5.84BA record high, above UBS's pre-call estimate of $5.80 billion.
- FQ3:26 non-GAAP EPSUS$1.47Above UBS's pre-call estimate of $1.39 and also above the high end of guidance.
- FQ3:26 non-GAAP gross margin49.9%Driven by customer and product mix as well as improved factory efficiency.
- FQ4:26 revenue guidance midpointUS$6.60BGuidance range is $6.20 billion to $7.00 billion.
- FQ4:26 non-GAAP EPS guidance midpointUS$1.65Guidance range is $1.50 to $1.80.
- C2026 WFE outlookapproximately US$140BManagement raised this from about $135 billion previously and said there is upside bias.
- Potential C2027 WFE sizeapproximately US$190B-200BUBS believes demand is sufficient to support this range.
- Long-term supportable WFE rangeapproximately US$240B-250BAssuming semiconductor revenue remains above about $2 trillion and equipment supply can support it.
- C2026E revenue/EPSUS$27.8B / US$7.23Raised from $27.0 billion / $6.83.
- C2027E revenue/EPSUS$39.9B / US$11.58Revenue and EPS are slightly adjusted from the prior $40.2 billion / $11.83.
- Market capitalizationUS$334BDisclosed in the report's trading data.
- China revenue share34%Slightly above the company's previous normalized statement of about 30% system revenue share.
Impact & implications
If UBS's view plays out, LRCX's investment thesis will shift from simply benefiting from Chinese equipment demand to benefiting from AI-driven global WFE expansion and share gains. The key to earnings upside is not only overall industry growth, but also LRCX's improved capture in NAND upgrades, DRAM etch, and advanced foundry/logic processes, along with pricing and gross margin improvement. The report also gives positive read-across to AMAT, KLAC, and ENTG, indicating that LRCX management's comments on WFE and capacity utilization may be beneficial to the broader semiconductor equipment and materials chain.
Risks
- Weaker macro demand could suppress semiconductor capital spending.
- Trade and geopolitical restrictions could affect equipment delivery priority for both China and non-China customers.
- Regulatory risk and intensifying competition could affect the path of share gains.
- LRCX has relatively high exposure to memory, especially NAND, and memory demand shocks would affect earnings and valuation.
- If C2028 memory revenue declines sharply, the assumption that WFE remains elevated will be challenged.
- If cleanroom and equipment supply constraints persist, they may limit near-term revenue realization.
- The service business is influenced by high industry utilization and could shift from strong growth to greater volatility later on.
What to watch
- Whether C2026 WFE continues to exceed approximately $140 billion and sees further upward revision.
- The pace of cleanroom supply improvement and greenfield project execution, especially large projects such as Terafab.
- The pace of spending against the NAND upgrade TAM of about $15 billion in C2026 and the remaining about $15 billion in C2027.
- LRCX Akara tool share gains in DRAM conductor etch.
- Equipment demand from foundry customers such as TSMC for A16 and backside power delivery.
- Changes in China revenue share and customer prepayments, especially whether China WFE grows at least about 10% year over year.
- Whether gross margin can remain near the FQ4:26 guidance level of about 50.5%.
- Whether C2027/C2028 EPS is realized along the path of about $12/$15.